Aluminum chloride hydroxide sulfate

Toxicological Summary

Workers - Hazard via inhalation route

Systemic effects

Long term exposure

Hazard assessment conclusion:

DNEL (Derived No Effect Level)

Value:

44.5 mg/m³

Most sensitive endpoint:

neurotoxicity

Route of original study:

Oral

DNEL related information

DNEL derivation method:

ECHA REACH Guidance

Overall assessment factor (AF):

12.5

Dose descriptor starting point:

NOAEL

Value:

631 mg/kg bw/day

Modified dose descriptor starting point:

NOAEC

Value:

556 mg/m³

Explanation for the modification of the dose descriptor starting point:

For potential inhalation exposure, route-to-route extrapolation from the oral NOAEL value (30 mg/kg bw/d) of aluminium and therefore631 mg/kg bw/d of Aluminium chloride hydroxide sulphate at 16.01% (via aluminium citrate in a read-across approach) was performed.  As specific data for the starting route (oral) is determined (see Toxicokinetics section) and extrapolated data is assumed for the end route (inhalation), assumptions have been made. Hence, it was determined that a limited absorption of 1% occurs by the oral route, leading to a conservative internal NOAEL based on the conservative absorption rate for both in animals and in Human (<<1% for aluminium citrate, aluminium chloride and Aluminium sulphate in Priest's study). By comparison, a similar conservative rate of absorption is assumed for the inhalation route (i.e. 1%) leading to a maximal external NOAEL. Moreover, in the case of oral-to-inhalation extrapolation, it is proposed to include an additional default factor of 2, i.e. the absorption percentage by oral route is half that of the inhalation absorption as suggested on page 19 of Guidance Document, Chapter R.8.  Finally, to convert the oral NOAEL into inhalatory NOAEC, a rat default respiratory volume was used corresponding to the daily duration of human exposure (sRVrat: 0.38 m3/kg bw/8 h).  For workers a correction was added for the difference between respiratory rates under standard conditions (sRVhuman: 6.7 m3 for an 8-h exposure period) and under conditions of light activity (wRV: 10 m3 for an 8-h exposure period). Thus, for aluminium chloride hydroxide sulphate, the corrected dose descriptor for inhalation is 556 mg/m3 for workers considering a molecular mass of 90.8 g/mol and a concentration of 16.01%.

AF for dose response relationship:

1

Justification:

Based on NOAEL [ECHA default, Chapter R8 guidance].

AF for differences in duration of exposure:

1

Justification:

The study exposed the animals until they were 1 year of age.

AF for interspecies differences (allometric scaling):

1

Justification:

Not applicable for oral to inhalation extrapolation [ECHA default, Chapter R8 guidance].

AF for other interspecies differences:

2.5

Justification:

Remaining differences between rat and human

AF for intraspecies differences:

5

Justification:

ECHA defaul for the workert, Chapter R8 guidance.

AF for the quality of the whole database:

1

Justification:

The available information as a whole meets the tonnage driven data requirement of REACH.

AF for remaining uncertainties:

1

Justification:

Reliability and consistency are observed across the different studies.

Acute/short term exposure

Hazard assessment conclusion:

no hazard identified

DNEL related information

Local effects

Long term exposure

Hazard assessment conclusion:

no hazard identified

Acute/short term exposure

Hazard assessment conclusion:

no hazard identified

DNEL related information

Workers - Hazard via dermal route

Systemic effects

Long term exposure

Hazard assessment conclusion:

DNEL (Derived No Effect Level)

Value:

12.6 mg/kg bw/day

Most sensitive endpoint:

neurotoxicity

Route of original study:

Oral

DNEL related information

DNEL derivation method:

ECHA REACH Guidance

Overall assessment factor (AF):

50

Dose descriptor starting point:

NOAEL

Value:

631 mg/kg bw/day

Modified dose descriptor starting point:

NOAEL

Value:

631 mg/kg bw/day

Explanation for the modification of the dose descriptor starting point:

For potential dermal exposure, route-to-route extrapolation from the oral NOAEL value (30 mg Aluminium /kg bw/d) was performed. The oral absorption rate is below 1% for Aluminiumchloride basic (see Toxicokinetics section). Moreover, in the absence of specific data about dermal absorption and on the assumption that, in general, dermal absorption will not be higher than oral absorption, no default factor should be introduced when performing oral to dermal extrapolation (see Guidance Document, Chapter R.8, pp 19). Thus, it is assumed that dermal absorption is not higher to 1% for Aluminium chloride hydroxide sulphate. Then, applying a correction factor based on the ratio between the molecular mass of Aluminium ion (26,98 g/mL) and Aluminium chloride hydroxide sulphate (90.8 g/Mol) together with the concentration of 16.01%, the corrected starting descriptor for Aluminium chloride hydroxide sulphate is 631 mg/kg bw/day.

AF for dose response relationship:

1

Justification:

Based on NOAEL [ECHA default, Chapter R8 guidance].

AF for differences in duration of exposure:

1

Justification:

The study exposed the animals until they were 1 year of age.

AF for interspecies differences (allometric scaling):

4

Justification:

Allometric scaling (rats to humans) [ECHA default, Chapter R8 guidance].

AF for other interspecies differences:

2.5

Justification:

Remaining differences between rat and human

AF for intraspecies differences:

5

Justification:

ECHA default for the worker, Chapter R8 guidance.

AF for the quality of the whole database:

1

Justification:

The available information as a whole meets the tonnage driven data requirement of REACH.

AF for remaining uncertainties:

1

Justification:

Moreover, reliability and consistency are observed across the different studies.

Acute/short term exposure

Hazard assessment conclusion:

no hazard identified

DNEL related information

Local effects

Long term exposure

Hazard assessment conclusion:

no hazard identified

Acute/short term exposure

Hazard assessment conclusion:

no hazard identified

Workers - Hazard for the eyes

Local effects

Hazard assessment conclusion:

low hazard (no threshold derived)

General Population - Hazard via inhalation route

Systemic effects

Long term exposure

Hazard assessment conclusion:

DNEL (Derived No Effect Level)

Value:

10.9 mg/m³

Most sensitive endpoint:

neurotoxicity

Route of original study:

Oral

DNEL related information

DNEL derivation method:

ECHA REACH Guidance

Overall assessment factor (AF):

25

Dose descriptor starting point:

NOAEL

Value:

631 mg/kg bw/day

Modified dose descriptor starting point:

NOAEC

Value:

274 mg/m³

Explanation for the modification of the dose descriptor starting point:

For potential inhalation exposure, route-to-route extrapolation from the oral NOAEL value (30 mg/kg bw/d) of aluminium and therefore 631 mg/kg bw/day of Aluminium chloride hydroxide sulphate at 16.01% (via aluminium citrate in a read-across approach) was performed.  As specific data for the starting route (oral) is determined (see Toxicokinetics section) and extrapolated data is assumed for the end route (inhalation), assumptions have been made. Hence, it was determined that a limited absorption of 1% occurs by the oral route, leading to a conservative internal NOAEL based on the conservative absorption rate for both in animals and in Human (<<1% for aluminium citrate, aluminium chloride and Aluminium sulphate in Priest's study). By comparison, a similar conservative rate of absorption is assumed for the inhalation route (i.e. 1%) leading to a maximal external NOAEL. Moreover, in the case of oral-to-inhalation extrapolation, it is proposed to include an additional default factor of 2, i.e. the absorption percentage by oral route is half that of the inhalation absorption as suggested on page 19 of Guidance Document, Chapter R.8.  Finally, to convert the oral NOAEL into inhalatory NOAEC, a rat default respiratory volume was used corresponding to the daily duration of human exposure (sRVrat: 1.15 m3/kg bw/24 h). Thus, for aluminium chloride hydroxide sulphate, the corrected dose descriptor for inhalation is 274 mg/m3 for workers considering a molecular mass of 90.8 g/Mol and a concentration of 16.01%.

AF for dose response relationship:

1

Justification:

Based on NOAEL [ECHA default, Chapter R8 guidance].

AF for differences in duration of exposure:

1

Justification:

The study exposed the animals until they were 1 year of age.

AF for interspecies differences (allometric scaling):

1

Justification:

Not applicable for oral to inhalation extrapolation [ECHA default, Chapter R8 guidance].

AF for other interspecies differences:

2.5

Justification:

Remaining differences between rat and human

AF for intraspecies differences:

10

Justification:

ECHA default for the worker, Chapter R8 guidance.

AF for the quality of the whole database:

1

Justification:

The available information as a whole meets the tonnage driven data requirement of REACH.

AF for remaining uncertainties:

1

Justification:

Reliability and consistency are observed across the different studies.

Acute/short term exposure

Hazard assessment conclusion:

no hazard identified

DNEL related information

Local effects

Long term exposure

Hazard assessment conclusion:

no hazard identified

Acute/short term exposure

Hazard assessment conclusion:

no hazard identified

DNEL related information

General Population - Hazard via dermal route

Systemic effects

Long term exposure

Hazard assessment conclusion:

DNEL (Derived No Effect Level)

Value:

6.3 mg/kg bw/day

Most sensitive endpoint:

neurotoxicity

Route of original study:

Oral

DNEL related information

DNEL derivation method:

ECHA REACH Guidance

Overall assessment factor (AF):

100

Dose descriptor starting point:

NOAEL

Value:

631 mg/kg bw/day

Modified dose descriptor starting point:

NOAEL

Value:

631 mg/kg bw/day

Explanation for the modification of the dose descriptor starting point:

For potential dermal exposure, route-to-route extrapolation from the oral NOAEL value (30 mg Aluminium /kg bw/d) was performed. The oral absorption rate is below 1% for Aluminiumchloride basic (see Toxicokinetics section). Moreover, in the absence of specific data about dermal absorption and on the assumption that, in general, dermal absorption will not be higher than oral absorption, no default factor should be introduced when performing oral to dermal extrapolation (see Guidance Document, Chapter R.8, pp 19). Thus, it is assumed that dermal absorption is not higher to 1% for Aluminium chloride hydroxide sulphate. Then, applying a correction factor based on the ratio between the molecular mass of Aluminium ion (26,98 g/mL) and Aluminium chloride hydroxide sulphate (90.8 g/Mol) together with the concentration of 16.01%, the corrected starting descriptor for Aluminium chloride hydroxide sulphate is 631 mg/kg bw/d.

AF for dose response relationship:

1

Justification:

Based on NOAEL [ECHA default, Chapter R8 guidance].

AF for differences in duration of exposure:

1

Justification:

The study exposed the animals until they were 1 year of age.

AF for interspecies differences (allometric scaling):

4

Justification:

Allometric scaling (rats to humans) [ECHA default, Chapter R8 guidance].

AF for other interspecies differences:

2.5

Justification:

Remaining differences between rat and human

AF for intraspecies differences:

10

Justification:

ECHA default the general population, Chapter R8 guidance.

AF for the quality of the whole database:

1

Justification:

The available information as a whole meets the tonnage driven data requirement of REACH.

AF for remaining uncertainties:

1

Justification:

Reliability and consistency are observed across the different studies.

Acute/short term exposure

Hazard assessment conclusion:

no hazard identified

DNEL related information

Local effects

Long term exposure

Hazard assessment conclusion:

no hazard identified

Acute/short term exposure

Hazard assessment conclusion:

no hazard identified

General Population - Hazard via oral route

Systemic effects

Long term exposure

Hazard assessment conclusion:

DNEL (Derived No Effect Level)

Value:

6.31 mg/kg bw/day

Most sensitive endpoint:

neurotoxicity

Route of original study:

Oral

DNEL related information

DNEL derivation method:

ECHA REACH Guidance

Overall assessment factor (AF):

100

Dose descriptor starting point:

NOAEL

Value:

631 mg/kg bw/day

Modified dose descriptor starting point:

NOAEL

Value:

631 mg/kg bw/day

Explanation for the modification of the dose descriptor starting point:

The major route of exposure to aluminium for the general population is through food. Mean concentrations of levels 5 to 10 mg/kg are found. Foods with very high mean concentrations included sources of natural origin e.g tea leaves, herbs and cocoa. Small amounts may come from food additives, and Al salts are also used in some pharmaceuticals, e.g over-the-counter medication against heartburn and effect enhances in injectable vaccins. On 2011, JECFA evaluated the new study described in the dossier (Developmental and One-Year Chronic Neurotoxicity Study of Aluminium Citrate in Rats). They considered that the developmental study provided a suitable and robust NOAEL for risk assessment (30 mg Al/kg bw/d, corresponding to 631 mg/kg bw/day of Aluminium chloride hydroxide sulphate at 16.01%). By appying the standard uncertainty factor of 100 to this NOAEL, the JECFA considered that it was appropriate to revise the provisional weekly tolerable intake (PTWI) upward to 2 mg Aluminium /kg bw/week. This corresponds to 42.1 mg Aluminium chloride hydroxide sulphate/kg bw/week considering a molecular mass of 90.8 g/Mol for the salt and a concentration of 16%. By calculation, an acceptable daily intake (ADI) can be extrapolated to 6.00 mg/kg bw/d for Aluminium chloride hydroxide sulphate (solution at 16.01%) which is closed to the long-term DNEL for systemic effect by oral (6.31 mg/kg bw/d). SCCS (2014) agrees on the NOAEL of 30 mg Aluminium / kg bw/d used by JECFA for risk assessment. On 2008, Scientific opinion of the panel on food additive, flavourings, processing aids and food conctact materials estimated a daily dietary exposure to aluminium in the general population in several European countries varied to 0.2 to 1.5 mg Al/kg bw/week at the mean and was up to 2.3 mg Aluminium/kg bw/week in highly exposed consumers.

AF for dose response relationship:

1

Justification:

Based on NOAEL [ECHA default, Chapter R8 guidance].

AF for differences in duration of exposure:

1

Justification:

The study exposed the animals until they were 1 year of age.

AF for interspecies differences (allometric scaling):

4

Justification:

Allometric scaling (rats to humans) [ECHA default, Chapter R8 guidance].

AF for other interspecies differences:

2.5

Justification:

Remaining differences between rat and human

AF for intraspecies differences:

10

Justification:

ECHA default for the general population, Chapter R8 guidance.

AF for the quality of the whole database:

1

Justification:

The available information as a whole meets the tonnage driven data requirement of REACH.

AF for remaining uncertainties:

1

Justification:

Reliability and consistency are observed across the different studies.

Acute/short term exposure

Hazard assessment conclusion:

no hazard identified

DNEL related information

General Population - Hazard for the eyes

Local effects

Hazard assessment conclusion:

low hazard (no threshold derived)